跳至主要内容
临床试验/EUCTR2020-001623-13-GR
EUCTR2020-001623-13-GR进行中(未招募)1 期

Triiodothyronine for the treatment of critically ill patients with COVID-19 infection (Thy-Support Study) - Thy-Support STUDY

ni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.0 个研究点目标入组 60 人开始时间: 2020年4月22日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients diagnosed with pulmonary infection due to COVID-19, admitted
  • in ICU and require mechanical ventilation or ECMO
  • Male and female with Age>18 years old
  • Signed informed consent from patient or relatives
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 40

排除标准

  • Pregnant or breast-feeding women
  • Severe systemic disease (e.g. cancer) before infection accompanied by reduced life expectancy <6 months
  • Participation in another trial of an investigational drug or device

研究者

发起方
ni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.

相似试验